Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea
· Delayed Price · Currency is KRW 8,510.00
+160.00 (1.92%)
At close: Apr 29, 2026
Keeps Biopharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 170,865 | 208,813 | 97,681 | 119,991 | 127,866 | 235,610 | Upgrade
|
| Market Cap Growth | -9.41% | 113.77% | -18.59% | -6.16% | -45.73% | -23.77% | Upgrade
|
| Enterprise Value | 256,379 | 254,805 | 122,355 | 160,512 | 124,281 | 215,414 | Upgrade
|
| Last Close Price | 8510.00 | 10400.00 | 5210.00 | 6400.00 | 6820.00 | 13100.00 | Upgrade
|
| PE Ratio | - | - | 87.73 | 30.53 | - | - | Upgrade
|
| Forward PE | - | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | Upgrade
|
| PS Ratio | 1.00 | 1.23 | 0.77 | 1.30 | 8.75 | 55.30 | Upgrade
|
| PB Ratio | 2.10 | 2.56 | 1.54 | 2.05 | 2.45 | 3.87 | Upgrade
|
| P/TBV Ratio | 16.14 | 19.72 | 10.43 | 4.50 | 2.45 | 3.92 | Upgrade
|
| P/OCF Ratio | - | - | 20.31 | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.51 | 1.50 | 0.96 | 1.74 | 8.50 | 50.56 | Upgrade
|
| EV/EBITDA Ratio | 59.62 | 42.03 | 13.89 | 35.65 | - | - | Upgrade
|
| EV/EBIT Ratio | - | 161.82 | 19.65 | 52.45 | - | - | Upgrade
|
| Debt / Equity Ratio | 1.14 | 1.14 | 0.88 | 0.83 | 0.55 | 0.45 | Upgrade
|
| Debt / EBITDA Ratio | 15.27 | 15.27 | 6.33 | 10.73 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.81 | 0.81 | 0.52 | 0.64 | 0.07 | -0.22 | Upgrade
|
| Net Debt / EBITDA Ratio | 10.89 | 10.89 | 3.72 | 8.31 | -0.46 | 1.16 | Upgrade
|
| Net Debt / FCF Ratio | -1.41 | -1.41 | -18.32 | -35.68 | -3.76 | 1.57 | Upgrade
|
| Asset Turnover | 0.85 | 0.85 | 0.90 | 0.91 | 0.16 | 0.05 | Upgrade
|
| Inventory Turnover | 5.10 | 5.10 | 8.57 | 22.90 | 7.05 | 4.01 | Upgrade
|
| Quick Ratio | 0.54 | 0.54 | 0.46 | 0.40 | 0.99 | 1.59 | Upgrade
|
| Current Ratio | 1.15 | 1.15 | 0.82 | 0.84 | 1.35 | 2.10 | Upgrade
|
| Return on Equity (ROE) | -14.33% | -14.33% | 2.64% | 6.25% | -21.28% | -29.03% | Upgrade
|
| Return on Assets (ROA) | 0.49% | 0.49% | 2.74% | 1.89% | -6.23% | -9.03% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.17% | 1.29% | 3.10% | 2.60% | -17.23% | -28.11% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.10% | 1.10% | 7.70% | 5.00% | -16.70% | -19.50% | Upgrade
|
| Earnings Yield | -5.73% | -4.69% | 1.14% | 3.28% | -8.90% | -6.50% | Upgrade
|
| FCF Yield | -27.42% | -22.44% | -1.83% | -0.87% | -0.75% | -3.60% | Upgrade
|
| Buyback Yield / Dilution | -3.91% | -3.91% | -0.31% | -0.40% | -8.22% | -18.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.